E Horak

4.7k total citations · 1 hit paper
11 papers, 1.0k citations indexed

About

E Horak is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E Horak has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E Horak's work include HER2/EGFR in Cancer Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cancer Treatment and Pharmacology (2 papers). E Horak is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cancer Treatment and Pharmacology (2 papers). E Horak collaborates with scholars based in United Kingdom and United States. E Horak's co-authors include Michael J. Greenall, Adrian L. Harris, S LeJeune, Russell Leek, N Stuart, K Smith, Kasia Stepniewska, David G. Jackson, Dawn L. Darling and Gregory D. Plowman and has published in prestigious journals such as The Lancet, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

E Horak

11 papers receiving 982 citations

Hit Papers

Angiogenesis, assessed by platelet/endothelial cell adhes... 1992 2026 2003 2014 1992 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Horak United Kingdom 8 667 438 411 119 113 11 1.0k
L Martín United Kingdom 10 682 1.0× 355 0.8× 446 1.1× 204 1.7× 101 0.9× 14 1.1k
Akeila Bellahcène Belgium 17 533 0.8× 536 1.2× 223 0.5× 174 1.5× 93 0.8× 22 1.1k
Yozo Kawano Japan 19 657 1.0× 435 1.0× 362 0.9× 331 2.8× 82 0.7× 28 1.2k
Nobuyoshi Momiyama Japan 17 373 0.6× 425 1.0× 401 1.0× 152 1.3× 102 0.9× 34 920
B Devictor France 18 340 0.5× 260 0.6× 156 0.4× 76 0.6× 93 0.8× 39 773
Maher N. Younes United States 19 517 0.8× 498 1.1× 169 0.4× 158 1.3× 83 0.7× 21 1.1k
Ulrike Lacher Germany 10 631 0.9× 295 0.7× 284 0.7× 88 0.7× 43 0.4× 14 942
Patrick Muraca United States 11 463 0.7× 373 0.9× 182 0.4× 256 2.2× 57 0.5× 11 994
J.S. de Jong Netherlands 11 443 0.7× 390 0.9× 297 0.7× 185 1.6× 26 0.2× 12 854
Hirokazu Amaya Japan 12 581 0.9× 369 0.8× 316 0.8× 242 2.0× 54 0.5× 20 913

Countries citing papers authored by E Horak

Since Specialization
Citations

This map shows the geographic impact of E Horak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Horak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Horak more than expected).

Fields of papers citing papers by E Horak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Horak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Horak. The network helps show where E Horak may publish in the future.

Co-authorship network of co-authors of E Horak

This figure shows the co-authorship network connecting the top 25 collaborators of E Horak. A scholar is included among the top collaborators of E Horak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Horak. E Horak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Geoffroy, F., et al.. (1994). Determinants of trimetrexate lethality in human colon cancer cells. British Journal of Cancer. 70(6). 1075–1084. 13 indexed citations
2.
LeJeune, S, Russell Leek, E Horak, et al.. (1993). Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer.. PubMed. 53(15). 3597–602. 80 indexed citations
3.
Harris, Adrian L. & E Horak. (1993). Growth Factors and Angiogenesis in Breast Cancer. Recent results in cancer research. 127. 35–41. 3 indexed citations
4.
Harris, Harriet L., Kevin C. Gatter, E Horak, et al.. (1993). p53 expression in human tumours: breast, lung, colon, bladder and prostate cancer;melanoma and lymphoma.. 175–179. 1 indexed citations
6.
Horak, E, Russell Leek, S LeJeune, et al.. (1992). Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. The Lancet. 340(8828). 1120–1124. 697 indexed citations breakdown →
7.
Lorenzen, Johann, et al.. (1991). Human tumour-associated NK cells secrete increased amounts of interferon-γ and interleukin-4. British Journal of Cancer. 64(3). 457–462. 24 indexed citations
8.
Horak, E, Kenneth T. Smith, S LeJeune, et al.. (1991). Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.. PubMed. 6(12). 2277–84. 80 indexed citations
9.
Stretch, Jonathan R., Karin Denton, P R Millard, & E Horak. (1991). Paget's disease of the male breast clinically and histopathologically mimicking melanoma. Histopathology. 19(5). 470–472. 19 indexed citations
10.
Horak, E, Dawn L. Darling, & David G. Jackson. (1986). Analysis of Organ-Specific Effects on Metastatic Tumor Formation by Studies In Vitro<xref ref-type="fn" rid="FN1">2</xref>. JNCI Journal of the National Cancer Institute. 76(5). 913–22. 72 indexed citations
11.
Horak, E, et al.. (1984). Intercellular junctions of methylcholanthrene-induced rat skin basocellular and squamous carcinomas. British Journal of Cancer. 49(5). 637–644. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026